Select M&A Deals and Terminations in the Age of Coronavirus

Select M&A Deals and Terminations in the Age of Coronavirus

(Terms not announced unless specified)

•     Beaver-Visitec Acquires Ophthalmic Viscoelastic Device Assets from Croma-Pharma (Austria)
•     Smiths Medical Acquires Access Scientific (US)
•     Zhuhai Baolian Asset Management Plans to Acquire Shanghai Kehua Bio-Engineering (China) -- Deal price -- $246.9m
•     OncBioMune Pharma to Acquire Avant Diagnostics (US)
•     Olink Proteomics Acquires Agrisera (Sweden)
•     Safe Orthopaedics Plans to Acquire LCI MEDICAL (France)
•     Cengiz Balcik and Yumnu Balcik Acquire Remaining 28% Stake in Yu-Ce Medical from Anatolia Growth Capital Fund (Turkey)
•     Safeguard Medical Acquires Water-Jel Technologies (US)
•     Aspen Surgical Acquires Precept Medical Products (US)
•     Conventus Orthopaedics to Acquire Flower Orthopedics (US)
•     Supernus Pharma to Acquire CNS Portfolio from US WorldMeds for $530m (US)
•     Alphatec Terminates $121.9m Agreement to Acquire EOS Imaging, Due to COVID-19
•     Ethicon Terminates $400m Acquisition of Tachosil from Takeda (Japan)
•     AK Medical International to Acquire Beijing Libeier Biology for $40.2m (China)
•     OrthoPediatrics Acquires ApiFix for $39.6m (Israel)
•     NZ Bidco Terminates $189.6m Acquisition of Abano Healthcare (New Zealand)